Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01825161
Other study ID # SPN-12-002
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 2013
Est. completion date December 2019

Study information

Verified date September 2022
Source AO Foundation, AO Spine
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The main purpose of this study is to utilize a comprehensive, prospective clinical database to collect patient, diagnostic and treatment variables along with disease specific and generic health related quality of life (HRQOL) data on consecutively treated patients with metastatic spine tumors. The objectives are to determine the validity and reliability of the Spine Cancer Outcomes Questionnaire (SCOQ) for use in the assessment of spine tumor outcomes, to determine if the Spine Instability Neoplastic Score (SINS) Classification is a valid tool for predicting the stability of spine in metastatic spine disease, and to determine the efficacy of surgery versus radiotherapy for the treatment of impending instability secondary to metastatic disease of the spine.


Recruitment information / eligibility

Status Completed
Enrollment 454
Est. completion date December 2019
Est. primary completion date December 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - Signed informed consent - Age between 18 and 75 years - Able to read and write English at an elementary level - Diagnosis of metastatic tumor of the spine Exclusion Criteria: - The primary cancer site is central nervous system or spine - History of substance abuse (recreational drugs, alcohol) within 12 months prior to screening - Is a prisoner - A disease or condition that would, in opinion of the investigator, preclude accurate evaluation (e.g. significant psychiatric disease)

Study Design


Related Conditions & MeSH terms

  • Neoplasms
  • Secondary Malignant Neoplasm of Vertebral Column

Locations

Country Name City State
Canada Montreal General Hospital Montreal Quebec
Canada Sunnybrook Health Sciences Center Toronto Ontario
Canada University of Toronto Hospital Toronto Ontario
Canada Vancouver General Hospital Vancouver British Columbia
Hungary National Center for Spinal Disorders Budapest
United States Johns Hopkins University Baltimore Maryland
United States MD Anderson Cancer Center Houston Texas
United States Kansas University Medical Center Kansas City Kansas
United States Hospital of the University of Pennsylvania Philadelphia Pennsylvania
United States Mayo Clinic Rochester Minnesota

Sponsors (2)

Lead Sponsor Collaborator
AO Foundation, AO Spine Orthopaedic Research Foundation

Countries where clinical trial is conducted

United States,  Canada,  Hungary, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Spine Cancer Outcomes Questionnaire (SCOQ) This is a new questionnaire, also referred to as the Spine Oncology Self-Assessment, developed by members of the SOSG. It is made up of 5 domains: physical function, neural function, pain, mental health and social function. It was developed as a comparison to the SF-36 for patients with spine tumors. The reliability and validity of this questionnaire will be compared with the SF-36v2. 0, 6, 12, 26, 52 and 104 weeks
Secondary Change in Pain Numeric Rating Scale (NRS) The Pain NRS is an 11-point horizontal scale where the end points are the extremes of no pain (0) and pain as bad as it could be, or worst pain (10). It measures subjective intensity of pain and the patient rates his/her overall or average daily pain. 0, 6, 12, 26, 52 and 104 weeks
Secondary Change in EuroQoL 5D (EQ-5D) The EuroQOL group developed a standardized instrument for use as a measure of health outcome. Applicable to a wide range of health conditions and treatments, it contains 5 questions and provides a simple descriptive profile and a single index value for health status. EQ-5D is designed for self-completion by respondents and is ideally suited for use in mailed surveys, in clinics and face-to-face interviews. It is cognitively simple, taking only a few minutes to complete. Instructions to respondents are included in the questionnaire. 0, 6, 12, 26, 52 and 104 weeks
Secondary Change in Short Form 36 version 2 (SF-36 v2) The SF-36 v2 (Medical Outcomes Trust, Boston, MA) is a multipurpose, short-form health survey with 36 questions available in several languages. It yields an eight-scale profile of scores: 1) limitations in physical activities because of health problems; 2) limitations in social activities because of physical or emotional problems; 3) limitations in usual role activities because of physical health problems; 4) bodily pain; 5) general mental health (psychological distress and well-being); 6) limitations in usual role activities because of emotional problems; 7) vitality (energy and fatigue); and 8) general health perceptions. In addition, two composite scores are constructed using factorial modeling, one for physical health (Physical Composite Score - PCS) and one for mental health (Mental Composite Score - MCS). 0, 6, 12, 26, 52 and 104 weeks
Secondary Change in International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) ISNCSCI is a standardized examination to determine neurologic function and has been a standard clinical assessment for patients with neurological deficit. The modified ISNCSCI used in this study will assess the Motor Score and the ASIA Impairment Scale V 1.3 only. 0, 6, 12, 26, 52 and 104 weeks